The Food and Drug Administration has issued new guidance spelling out its policy for organizations using electronic health record data in FDA-regulated clinical investigations, such as studies of the long-term safety and effectiveness of various drugs. Among other criteria, the EHRs need to contain certain privacy and security controls, the FDA says.
Marti Arvin's comments are featured in the article.